Literature DB >> 9013630

Overlapping expression and redundant activation of mesenchymal fibroblast growth factor (FGF) receptors by alternatively spliced FGF-8 ligands.

A G Blunt1, A Lawshé, M L Cunningham, M L Seto, D M Ornitz, C A MacArthur.   

Abstract

FGF-8 is a member of the family of fibroblast growth factors and is expressed during vertebrate embryo development. Eight potential FGF-8 isoforms are generated by alternative splicing in mice, several of which are expressed during embryogenesis in epithelial locations. The significance of the multiple isoforms is currently unknown. In this report, we investigate the expression patterns and the specificity of the FGF-8 isoforms for known fibroblast growth factor (FGF) receptors. RNAs for seven of the eight potential isoforms are present at multiple sites of embryonic Fgf8 expression. None of the FGF-8 isoforms exhibited activity when assayed with BaF3 cells expressing the "b" splice forms of FGF receptors 1-3, which are mostly expressed in epithelial tissues. Mesenchymally expressed "c" splice forms of FGF receptors 2 and 3 and FGF receptor 4 were activated by several FGF-8 isoforms. These findings are consistent with the hypothesis that the multiple FGF-8 isoforms are functionally redundant and function to signal in paracrine (epithelial to mesenchymal) contexts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013630     DOI: 10.1074/jbc.272.6.3733

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  fus/TLS orchestrates splicing of developmental regulators during gastrulation.

Authors:  Darwin S Dichmann; Richard M Harland
Journal:  Genes Dev       Date:  2012-06-15       Impact factor: 11.361

Review 2.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

Review 3.  Numerous isoforms of Fgf8 reflect its multiple roles in the developing brain.

Authors:  N Abimbola Sunmonu; Kairong Li; James Y H Li
Journal:  J Cell Physiol       Date:  2011-07       Impact factor: 6.384

4.  A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma.

Authors:  S Tanaka; H Ueo; K Mafune; M Mori; J R Wands; K Sugimachi
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

Review 5.  Fibroblast growth factor control of cartilage homeostasis.

Authors:  M B Ellman; D Yan; K Ahmadinia; D Chen; H S An; H J Im
Journal:  J Cell Biochem       Date:  2013-04       Impact factor: 4.429

6.  Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice.

Authors:  John Falardeau; Wilson C J Chung; Andrew Beenken; Taneli Raivio; Lacey Plummer; Yisrael Sidis; Elka E Jacobson-Dickman; Anna V Eliseenkova; Jinghong Ma; Andrew Dwyer; Richard Quinton; Sandra Na; Janet E Hall; Celine Huot; Natalie Alois; Simon H S Pearce; Lindsay W Cole; Virginia Hughes; Moosa Mohammadi; Pei Tsai; Nelly Pitteloud
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

Review 7.  Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology.

Authors:  Artur A Belov; Moosa Mohammadi
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-06-01       Impact factor: 10.005

8.  The splicing factor PQBP1 regulates mesodermal and neural development through FGF signaling.

Authors:  Yasuno Iwasaki; Gerald H Thomsen
Journal:  Development       Date:  2014-09-10       Impact factor: 6.868

9.  The duration of Fgf8 isthmic organizer expression is key to patterning different tectal-isthmo-cerebellum structures.

Authors:  Tatsuya Sato; Alexandra L Joyner
Journal:  Development       Date:  2009-09-30       Impact factor: 6.868

10.  FGF8 isoform b expression in human prostate cancer.

Authors:  V J Gnanapragasam; M C Robinson; C Marsh; C N Robson; F C Hamdy; H Y Leung
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.